A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps

Figure 4

ROC analyses of CEA (a) and CYFRA 21-1 (b) to distinguish breast cancer patients from benign breast disease patients.

(a)

(b)